{"id":311908,"date":"2020-01-03T20:16:12","date_gmt":"2020-01-04T04:16:12","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/01\/leap-therapeutics-and-beigene-announce-exclusive-option-and-license-agreement\/"},"modified":"2020-01-03T20:16:45","modified_gmt":"2020-01-04T04:16:45","slug":"leap-therapeutics-%e5%92%8c%e4%b8%ad%e5%9c%8b%e4%bc%81%e6%a5%ad%e9%81%94%e6%88%90%e5%85%8d%e7%96%ab%e8%85%ab%e7%98%a4%e8%97%a5%e7%89%a9%e6%8e%88%e6%ac%8a%e8%a8%b1%e5%8f%af%e5%8d%94%e8%ad%b0","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2020\/01\/leap-therapeutics-%e5%92%8c%e4%b8%ad%e5%9c%8b%e4%bc%81%e6%a5%ad%e9%81%94%e6%88%90%e5%85%8d%e7%96%ab%e8%85%ab%e7%98%a4%e8%97%a5%e7%89%a9%e6%8e%88%e6%ac%8a%e8%a8%b1%e5%8f%af%e5%8d%94%e8%ad%b0\/","title":{"rendered":"Leap Therapeutics\u548c\u4e2d\u570b\u4f01\u696d\u9054\u6210\u514d\u75ab\u816b\u7624\u85e5\u7269\u6388\u6b0a\u8a31\u53ef\u5354\u8b70"},"content":{"rendered":"<p>\u958b\u767c\u9776\u5411\u514d\u75ab\u816b\u7624\u7642\u6cd5\u7684\u751f\u7269\u6280\u8853\u516c\u53f8Leap Therapeutics\uff0cInc.\uff08Nasdaq\uff1aLPTX\uff09\u548c\u5c08\u6ce8\u4e8e\u958b\u767c\u548c\u5546\u696d\u5316\u5275\u65b0\u5206\u5b50\u7684\u5546\u696d\u5316\u751f\u7269\u88fd\u85e5\u516c\u53f8\u767e\u6fdf\u795e\u5dde\u5ba3\u4f48\uff0c\u5c31Leap Therapeutics\u7684Dickkopf-1\uff08DKK1\uff09\u6297\u9ad4DKN-01\u5728\u4e9e\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9e\u548c\u65b0\u897f\u862d\u7684\u81e8\u5e8a\u958b\u767c\u548c\u5546\u696d\u5316\u9054\u6210\u4e86\u7368\u5bb6\u9078\u64c7\u6b0a\u548c\u8a31\u53ef\u5354\u8b70\u3002Leap Therapeutics\u5c07\u4fdd\u7559\u5728\u4e16\u754c\u5176\u4ed6\u5730\u5340\u958b\u767c\u3001\u751f\u7522\u548c\u5546\u696d\u5316DKN-01\u7684\u7368\u5bb6\u6b0a\u5229\u3002\u6b64\u5916\uff0cLeap Therapeutics\u5ba3\u4f48\u8207\u767e\u6fdf\u795e\u5dde\u548c\u5169\u5bb6\u6a5f\u69cb\u6295\u8cc7\u8005\u9054\u6210\u4e00\u98052700\u842c\u7f8e\u5143\u7684\u80a1\u6b0a\u878d\u8cc7\u5354\u8b70\u3002<\/p>\n<p>\u767e\u6fdf\u795e\u5dde\u514d\u75ab\u816b\u7624\u5b78\u9996\u5e2d\u91ab\u5b78\u5b98\u8cc1\u52c7\u91ab\u5b78\u535a\u58eb\u8868\u793a\uff1a\u201c\u6211\u5011\u5f88\u9ad8\u8208\u80fd\u5920\u63a2\u7d22\u6297PD-1\u6297\u9ad4\u66ff\u96f7\u5229\u73e0\u55ae\u6297\u8207DKN-01\u7684\u806f\u5408\u7642\u6cd5\uff0cDKN-01\u8fc4\u4eca\u70ba\u6b62\u5728\u751f\u7269\u6a19\u8a8c\u7269\u5b9a\u7fa9\u7684\u80c3\u764c\u60a3\u8005\u4e2d\u548c\u514d\u75ab\u6aa2\u67e5\u9ede\u6291\u5236\u5291\u7d50\u5408\u8868\u73fe\u7a4d\u6975\u3002\u8207Leap Therapeutics\u7684\u5408\u4f5c\u662f\u6211\u5011\u81f4\u529b\u65bc\u958b\u767c\u5275\u65b0\u7642\u6cd5\u4ee5\u6eff\u8db3\u4e9e\u6d32\u548c\u4e16\u754c\u5404\u5730\u5c1a\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u7684\u53c8\u4e00\u4f8b\u8b49\u3002\u201d<\/p>\n<p>\u6839\u64da\u5354\u8b70\u689d\u6b3e\uff0cLeap Therapeutics\u5c07\u5f9e\u767e\u6fdf\u795e\u5dde\u7372\u5f97300\u842c\u7f8e\u5143\u7684\u9810\u4ed8\u73fe\u91d1\u4ed8\u6b3e\uff0c\u767e\u6fdf\u795e\u5dde\u5c07\u7372\u5f97\u5728\u4e9e\u6d32\uff08\u65e5\u672c\u9664\u5916\uff09\u3001\u6fb3\u5927\u5229\u4e9e\u548c\u65b0\u897f\u862d\u958b\u767c\u548c\u5546\u696d\u5316DKN-01\u7684\u7368\u5bb6\u6388\u6b0a\u8a31\u53ef\u3002<\/p>\n<p>Leap Therapeutics\u516c\u53f8\u7e3d\u88c1\u517c\u9996\u5e2d\u57f7\u884c\u5b98Christopher K. Mirabelli\u535a\u58eb\u8868\u793a\uff1a\u201c\u5c31\u9032\u4e00\u6b65\u958b\u767cDKN-01\u958b\u5c55\u5408\u4f5c\u4e00\u76f4\u662f\u6211\u5011\u7684\u9996\u8981\u6230\u7565\u91cd\u9ede\u3002\u6211\u5011\u5f88\u9ad8\u8208\u958b\u59cb\u8207\u5168\u7403\u816b\u7624\u9818\u57df\u7684\u9818\u5c0e\u8005\u767e\u6fdf\u795e\u5dde\u7684\u5408\u4f5c\uff0c\u767e\u6fdf\u795e\u5dde\u662fLeap Therapeutics\u7684\u7406\u60f3\u5408\u4f5c\u5925\u4f34\uff0c\u4ed6\u5011\u5728\u4e9e\u592a\u5730\u5340\u7684\u816b\u7624\u85e5\u7269\u958b\u767c\u65b9\u9762\u64c1\u6709\u8c50\u5bcc\u7684\u7d93\u9a57\uff0c\u4ed6\u5011\u7684\u5c08\u696d\u77e5\u8b58\u548c\u8c50\u5bcc\u7684\u7522\u54c1\u5c07\u652f\u6301\u6211\u5011\u6eff\u8db3\u5728\u98df\u7ba1\u80c3\u3001\u5a66\u79d1\u548c\u5176\u4ed6\u764c\u75c7\u65b9\u9762\u9060\u672a\u88ab\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u7684\u52aa\u529b\u3002\u201d<\/p>\n<p>\u5728\u9078\u64c7\u6b0a\u6709\u6548\u671f\u5167\uff0cLeap Therapeutics\u540c\u610f\u5c31DKN-01\u548c\u66ff\u96f7\u5229\u73e0\u55ae\u6297\u806f\u5408\u7642\u6cd5\u958b\u5c55\u7814\u7a76\u3002\u6b64\u5916\uff0cLeap Therapeutics\u8a08\u5283\u5728\u7d0420\u4f8b\u4e00\u7dda\u80c3\u817a\/\u80c3\u98df\u7ba1\u7d50\u5408\u90e8\u764c\u60a3\u8005\u4e2d\u8a55\u4f30DKN-01\u8207\u66ff\u96f7\u5229\u73e0\u55ae\u6297\u548c\u5316\u7642\u806f\u5408\u6cbb\u7642\u7684\u7642\u6548\u3002Leap Therapeutics\u9810\u8a08\u5c07\u57282020\u5e74\u4e0a\u534a\u5e74\u555f\u52d5\u9019\u4e9b\u81e8\u5e8a\u8a66\u9a57\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p> Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company developing targeted immuno-oncology therapeutics, and BeiGene Co.,Ltd (Nasdaq: BGNE; HKEX: 06160)<\/p>\n","protected":false},"author":9,"featured_media":311902,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,644,564],"class_list":["post-311908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag-644","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/311908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=311908"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/311908\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/311902"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=311908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=311908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=311908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}